Newborn screening for primary immunodeficiencies: beyond SCID and XLA.
about
Newborn screening for SCID in New York State: experience from the first two years.T-cell Receptor and K-deleting Recombination Excision Circles in Newborn Screening of T- and B-cell Defects: Review of the Literature and Future Challenges.Placental transfer of maternally-derived IgA precludes the use of guthrie card eluates as a screening tool for primary immunodeficiency diseases.The TREC/KREC assay for the diagnosis and monitoring of patients with DiGeorge syndrome.A Novel Targeted Screening Tool for Hypogammaglobulinemia: Measurement of Serum Immunoglobulin (IgG, IgM, IgA) Levels from Dried Blood Spots (Ig-DBS Assay).Newborn Screening for Severe Primary Immunodeficiency Diseases in Sweden-a 2-Year Pilot TREC and KREC Screening StudyThe case for mandatory newborn screening for severe combined immunodeficiency (SCID).A Comparative Study of Intravenous Immunoglobulin and Subcutaneous Immunoglobulin in Adult Patients with Primary Immunodeficiency Diseases: A Systematic Review and Meta-Analysis.Advances in neonatal screening for primary immune deficiencies.Immunodeficiencies Associated with Abnormal Newborn Screening for T Cell and B Cell Lymphopenia.Prospective neonatal screening for severe T- and B-lymphocyte deficiencies in Seville.Retrospective analysis of TREC based newborn screening results and clinical phenotypes in infants with the 22q11 deletion syndrome.Selectivity analysis of single binder assays used in plasma protein profilingEight-color immunophenotyping of T-, B-, and NK-cell subpopulations for characterization of chronic immunodeficiencies.Cost-effectiveness analysis of subcutaneous immunoglobulin replacement therapy in Iranian patients with primary immunodeficiencies.
P2860
Q33877733-800FD6FE-3518-4153-86E7-0F5D396F27CDQ34074060-8E4ACB8C-D587-40A5-BC2F-B71D1C40271EQ34391579-EF4BC15A-A543-4C65-A2C3-7F5011F76923Q34653931-5BF095DA-E2FC-4A51-B0ED-A7D164DA1462Q36065390-D34BAE97-0EF0-4AA6-80E7-7B57217F7527Q37580857-12FB4436-A5B6-456B-83F5-2CEBA8C50E62Q38201349-6C3B7ECC-A400-4D58-8F00-0F99F991DAB3Q38744512-D5359918-A42E-4927-9B00-4B4413E57429Q38832208-78FAD532-962D-4275-8E96-20D9A03D03E5Q39206354-5FF03147-1234-44FF-A401-6DE0D5CDBF34Q40396576-CEBDA71A-0C80-4A36-A37D-DF87A36589E0Q42232829-6499032D-CA00-4B45-8C81-1A21BA5BF7E9Q42597820-6648D94F-DA99-43F5-BE74-73D93680447BQ46129819-269FDC7D-F092-4CFA-9619-2F8A4647B8B6Q55311044-7C416DC1-8EAA-43E5-A842-49688CDA09AC
P2860
Newborn screening for primary immunodeficiencies: beyond SCID and XLA.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Newborn screening for primary immunodeficiencies: beyond SCID and XLA.
@en
Newborn screening for primary immunodeficiencies: beyond SCID and XLA.
@nl
type
label
Newborn screening for primary immunodeficiencies: beyond SCID and XLA.
@en
Newborn screening for primary immunodeficiencies: beyond SCID and XLA.
@nl
prefLabel
Newborn screening for primary immunodeficiencies: beyond SCID and XLA.
@en
Newborn screening for primary immunodeficiencies: beyond SCID and XLA.
@nl
P2093
P2860
P1476
Newborn screening for primary immunodeficiencies: beyond SCID and XLA.
@en
P2093
Lennart Hammarström
Stephan Borte
Sólveig Oskarsdóttir
Ulrika von Döbeln
P2860
P304
P356
10.1111/J.1749-6632.2011.06350.X
P407
P577
2011-12-01T00:00:00Z